Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $19.96

Pulse Biosciences, Inc. (NASDAQ:PLSE)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $19.96, but opened at $19.19. Pulse Biosciences shares last traded at $19.19, with a volume of 1,747 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of Pulse Biosciences to a “sell” rating in a report on Tuesday, August 6th.

Pulse Biosciences Stock Down 4.3 %

The company has a fifty day moving average of $14.65 and a 200 day moving average of $11.09. The company has a market cap of $1.01 billion, a P/E ratio of -23.69 and a beta of 1.75.

Institutional Trading of Pulse Biosciences

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets lifted its position in Pulse Biosciences by 63.6% during the first quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after purchasing an additional 2,952 shares in the last quarter. Quest Partners LLC purchased a new position in Pulse Biosciences during the second quarter valued at approximately $91,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Pulse Biosciences in the first quarter worth $88,000. Cetera Advisors LLC bought a new stake in shares of Pulse Biosciences during the 1st quarter valued at $109,000. Finally, PNC Financial Services Group Inc. purchased a new position in shares of Pulse Biosciences during the 4th quarter valued at $242,000. 76.95% of the stock is owned by hedge funds and other institutional investors.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.